AbbVie Inc.
ABBV
$166.41
$1.751.06%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 822.00M | 1.78B | 2.02B | 239.00M | 2.47B |
| Total Depreciation and Amortization | 2.08B | 2.24B | 2.26B | 2.13B | 2.16B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.41B | 918.00M | 1.48B | 2.65B | 1.95B |
| Change in Net Operating Assets | 443.00M | 2.64B | 552.00M | -825.00M | 846.00M |
| Cash from Operations | 4.75B | 7.57B | 6.32B | 4.19B | 7.43B |
| Capital Expenditure | -205.00M | -219.00M | -178.00M | -175.00M | -213.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -553.00M | -157.00M | -160.00M | -353.00M | -300.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -42.00M | 7.00M | -3.00M | 29.00M | 65.00M |
| Cash from Investing | -800.00M | -369.00M | -341.00M | -499.00M | -448.00M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -1.79B | -2.00M | -1.00B | -1.35B | -6.85B |
| Issuance of Common Stock | 31.00M | 36.00M | 48.00M | 65.00M | 53.00M |
| Repurchase of Common Stock | -3.00M | -4.00M | -10.00M | -1.96B | -4.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.63B | -2.63B | -2.63B | -2.66B | -2.51B |
| Other Financing Activities | -57.00M | -64.00M | -331.00M | -290.00M | -326.00M |
| Cash from Financing | -4.45B | -2.66B | -3.92B | -6.19B | -9.63B |
| Foreign Exchange rate Adjustments | 23.00M | -16.00M | -10.00M | 8.00M | 23.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -473.00M | 4.53B | 2.05B | -2.49B | -2.63B |
